Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Loxapine succinate

🥰Excellent
Catalog No. T1412Cas No. 27833-64-3
Alias Loxapine succinate salt, Loxapac, Daxolin, Cloxazepin

Loxapine succinate (Loxapac), a D2DR and D4DR inhibitor, is utilized in schizophrenia.

Loxapine succinate

Loxapine succinate

🥰Excellent
Purity: 99.92%
Catalog No. T1412Alias Loxapine succinate salt, Loxapac, Daxolin, CloxazepinCas No. 27833-64-3
Loxapine succinate (Loxapac), a D2DR and D4DR inhibitor, is utilized in schizophrenia.
Pack SizePriceAvailabilityQuantity
50 mg$33In Stock
100 mg$47In Stock
200 mg$76In Stock
500 mg$167In Stock
1 mL x 10 mM (in DMSO)$52In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Loxapine succinate"

Select Batch
Purity:99.92%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Loxapine succinate (Loxapac), a D2DR and D4DR inhibitor, is utilized in schizophrenia.
Targets&IC50
D2 receptor (human):24 nM(Ki), 5-HT2 (human):6.2 nM(Ki), 5-HT2 (bovine):6.6 nM(Ki), 5-HT2 (bovine):6.8 nM(Ki), D4 receptor (human):7.5 nM(Ki)
In vitro
In rats, subcutaneous injection of Loxapine (0.3 mg/kg) induces general stiffness. In the rat brain, administering Loxapine (5 mg/kg) does not alter dopamine receptor density, but it reduces serotonin receptor density.
In vivo
Loxapine effectively facilitates the binding of [3H]ketanserin to 5-HT2 receptors in both the human frontal cortex (ki=6.2 nM) and the bovine frontal cortex (ki=6.6 nM). Additionally, in LPS-activated mixed glial cells, loxapine at concentrations of 0.2 μM, 2 μM, and 20 μM, successfully reduces the secretion of IL-1β and IL-2.
AliasLoxapine succinate salt, Loxapac, Daxolin, Cloxazepin
Chemical Properties
Molecular Weight445.9
FormulaC22H24ClN3O5
Cas No.27833-64-3
SmilesOC(=O)CCC(=O)O.CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 2 mg/mL (4.48 mM)
DMSO: 82 mg/mL (183.9 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.2427 mL11.2133 mL22.4266 mL112.1328 mL
DMSO
1mg5mg10mg50mg
5 mM0.4485 mL2.2427 mL4.4853 mL22.4266 mL
10 mM0.2243 mL1.1213 mL2.2427 mL11.2133 mL
20 mM0.1121 mL0.5607 mL1.1213 mL5.6066 mL
50 mM0.0449 mL0.2243 mL0.4485 mL2.2427 mL
100 mM0.0224 mL0.1121 mL0.2243 mL1.1213 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Loxapine succinate | purchase Loxapine succinate | Loxapine succinate cost | order Loxapine succinate | Loxapine succinate chemical structure | Loxapine succinate in vivo | Loxapine succinate in vitro | Loxapine succinate formula | Loxapine succinate molecular weight